Novel psychoactive substances. [PDF]
Br J Gen Pract, 2016 Gilani does well to highlight the increasing and concerning use of novel psychoactive substances (NPS) in the UK.1 We have seen the damaging and unpredictable effects of synthetic cannabinoids in prisons …
Brew I.
europepmc +7 more sources
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. [PDF]
Brain Sci, 2018 Recently, a range of prescription and over-the-counter drugs have been reportedly used as Novel Psychoactive Substances (NPS), due to their potential for abuse resulting from their high dosage/idiosyncratic methods of self-administration.
Schifano F +3 more
europepmc +2 more sources
Sex and Gender Differences in the Effects of Novel Psychoactive Substances. [PDF]
Brain Sci, 2020 Sex and gender deeply affect the subjective effects and pharmaco-toxicological responses to drugs. Men are more likely than women to use almost all types of illicit drugs and to present to emergency departments for serious or fatal intoxications. However, women are just as likely as men to develop substance use disorders, and may be more susceptible to
Fattore L +3 more
europepmc +7 more sources
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances. [PDF]
Brain Sci, 2020 Objective: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals (HCPs). The study also aimed to assess how HCPs would like to improve their knowledge of NPS.
Ramos C +9 more
europepmc +2 more sources
Novel psychoactive substances and behavioral addictions. [PDF]
Biomed Res Int, 2014 Copyright © 2014 Giovanni Martinotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Martinotti G +3 more
europepmc +9 more sources
Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon. [PDF]
Brain Sci, 2018 Over the last decade, the emergence of a vast range of new/novel/emerging psychoactive substances (NPS) has progressively changed drug market scenarios, which have shifted from the ‘street’ to a ‘virtual’/online environment. [...]
Schifano F.
europepmc +2 more sources
Novel psychoactive substances: the pharmacology of stimulants and hallucinogens [PDF]
Expert Review of Clinical Pharmacology, 2016 There are increasing levels of concern relating to the rapidly evolving novel psychoactive substances/NPS and web markets' scenarios. The paper aims at providing an overview of the clinical pharmacological issues related to some of the most popular NPS categories, e.g. stimulants and hallucinogens.
John Martin Corkery +2 more
exaly +3 more sources
Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects. [PDF]
Brain Sci, 2020 New/novel psychoactive substances (NPS) are defined as new narcotic/psychotropic drugs which are not controlled by the United Nations’ 1961 Narcotic Drugs/1971 Psychotropic Substances conventions, but which may pose a public health threat [...]
Schifano F.
europepmc +2 more sources
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
Medicina (Lithuania), 2021 Background and Objectives: Over the past twenty years a large number of new psychoactive substances (NPS) have entered and modified the recreational drug scene.
Amira Guirguis +2 more
exaly +3 more sources
An Expanding World of Novel Psychoactive Substances: Opioids. [PDF]
Front Psychiatry, 2017 The abuse of novel psychoactive substances (NPS) has been increasing dramatically worldwide since late 2000s. By the end of 2015, more than 560 NPS had been reported to the European Monitoring Centre for Drugs and Drug Addiction. Although the most popular compounds are synthetic cannabinoids and psychostimulatory derivatives of cathinone (so-called β ...
Zawilska JB.
europepmc +5 more sources